ARTIDIS announces publication demonstrating the nanomechanical signature of response to low-dose radiotherapy followed by CAR T cell therapy in solid tumors.

Scientific Communications & Research Intern

ARTIDIS AG is a clinical-stage health-tech start-up based in Basel, Switzerland, focusing on cancer diagnosis and treatment optimization through its innovative nanotechnology platform. The Scientific Communications & Research Intern will support scientific engagement and business development by creating materials, conducting research, and preparing for presentations and collaborations.

Sign up with Google

Sign in with Google